logo

Magenta Therapeutics, Inc. (MGTA)



Trade MGTA now with
  Date
  Headline
5/16/2022 8:17:47 AM Magenta Therapeutics Q1 Net Loss $23.0 Mln Vs. Net Loss Of $17.5 Mln Prior Year
3/8/2022 8:08:20 AM Magenta Therapeutics Q4 Net Loss $19.3 Mln Vs. Net Loss $18.2 Mln Last Year
10/4/2021 8:05:27 AM Magenta Therapeutics Appoints Jeffrey Humphrey As Chief Medical Officer
9/15/2021 8:23:02 AM Magenta Therapeutics Announces IND Clearance For MGTA-117 Targeted Conditioning Clinical Trial
7/21/2021 8:07:10 AM Magenta Therapeutics Gets Clinical Hold Letter From FDA Regarding IND On Acute Myeloid Leukemia And MDS
7/6/2021 8:04:31 AM Magenta Therapeutics Appoints Caren Deardorf As Chief Commercial Officer
5/12/2021 10:08:40 AM Magenta Therapeutics To Sell Around 9,600,000 Shares To Certain Institutional Investors In A Private Placement
4/19/2021 8:04:19 AM Magenta Therapeutics Appoints David Nichols As Chief Technical Officer
5/10/2019 7:50:46 AM Wedbush Is Increasing Magenta Therapeutics, Inc. (MGTA) FY19 Estimate To -1.97 From -2.49
5/10/2019 7:50:32 AM Wedbush Is Raising Magenta Therapeutics, Inc. (MGTA) Q4 19 Estimate To -0.53 From -0.67
5/10/2019 7:50:09 AM Wedbush Is Raising Magenta Therapeutics, Inc. (MGTA) Q3 19 Estimate To -0.48 From -0.60
5/10/2019 7:49:56 AM Wedbush Is Raising Magenta Therapeutics, Inc. (MGTA) Q2 19 Estimate To -0.51 From -0.63
5/10/2019 7:49:24 AM Wedbush Reiterates Magenta Therapeutics, Inc. (MGTA) At Outperform With $22 Price Target
8/10/2018 7:28:40 AM Wedbush Is Increasing Magenta Therapeutics, Inc. (MGTA) FY19 Estimate To -2.09 From -2.19
8/10/2018 7:28:23 AM Wedbush Is Raising Magenta Therapeutics, Inc. (MGTA) Q4 19 Estimate To -0.58 From -0.60
8/10/2018 7:28:09 AM Wedbush Is Raising Magenta Therapeutics, Inc. (MGTA) Q3 19 Estimate To -0.51 From -0.54
8/10/2018 7:27:52 AM Wedbush Is Raising Magenta Therapeutics, Inc. (MGTA) Q2 19 Estimate To -0.53 From -0.55